Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +9.3% | -6.0% | 2 / 3 | +14.2% | +0.44 pp | -0.75 pp | +40.1% | 0.46 | 23.10 | 7.165 | +14,2% | 1.484 | +10,2% | 23.10 | 14.94 | +54,6% |
| Pts | 0 | 0 | 8 | 4 | 8 | 4 | 12 | 12 | 4 | |||||||
Valuation annotation:Price: 139.800 (close price on 2026-10-19)EPS (TTM): 6.053
Financial charts
1.Revenue & growth
VND bn7.165Q2/26
1.Revenue & growth
VND bn7.165Q2/26
2.Profit & growth
VND bn1.471Q2/26
3.Profit mix (Penman)
VND bn8.210Q2/26
4.Margins & cost structure
%45.6%Q2/26
5.Returns & cash cycle
% · days36.4%Q2/26
6.Earnings quality & cash
VND bn4.295Q2/26
7.Asset structure
VND bn33.634Q2/26
8.Funding & debt health
VND bn · times33.634Q2/26
9.Revenue backlog
VND bn132Q2/26
10.Valuation
times · %26,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.137Q2/26
Adjusted EPS growth, latest quarter
11.6%
Average adjusted EPS growth, 3 quarters
-4.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.5%
Source: vnstockData through Q2/26